Literature DB >> 17706955

Increased plasma C-reactive protein and interleukin-6 concentrations in patients with slow coronary flow.

Jian-Jun Li1, Xue-Wen Qin, Zi-Cheng Li, He-Song Zeng, Zhan Gao, Bo Xu, Chao-Yang Zhang, Jie Li.   

Abstract

BACKGROUND: Slow coronary filling of epicardial coronary arteries in the absence of stenosis is not infrequently detected finding during routine coronary angiography. There is mounting evidence suggested that an inflammatory process play an important role in atherosclerotic pathogenesis appeared in different clinical settings. However, the possible association between inflammation and slow coronary flow (SCF) has not been investigated. We examined whether the increased inflammatory markers are present in patients with SCF.
METHODS: Forty-two patients with SCF detected by coronary angiography via the Thrombosis In Myocardial Infarction (TIMI) frame count method were enrolled in this study. The plasma concentration of high-sensitivity C-reactive protein (CRP) and interleukin-6 (IL-6) were evaluated using commercial available kits. Data were compared with 30 control subjects with angiographically normal coronary flow.
RESULTS: There are no differences regarding clinical characteristics between the 2 groups. The data showed, however, that plasma CRP and IL-6 concentrations were higher in patients with SCF compared with normal control subject (CRP: 0.27 +/- 0.16 vs. 0.22 +/- 0.11mg/l; and IL-6: 8.7 +/- 0.8 vs. 5.4 +/- 0.4pg/ml, p < 0.01 respectively). In addition, mean TIMI frame count was positively correlated with plasma CRP and IL-6 concentrations (CRP: gamma = 0.551; IL-6: gamma = 0.573, p < 0.01 respectively).
CONCLUSIONS: Plasma concentration of CRP and IL-6 concentrations increased, and was positive correlated with TIMI frame count in patients with SCF compared with normal coronary flow subject. Therefore, whether the increased inflammatory markers are related to the pathogenesis of SCF in these patients deserved further investigation.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17706955     DOI: 10.1016/j.cca.2007.05.024

Source DB:  PubMed          Journal:  Clin Chim Acta        ISSN: 0009-8981            Impact factor:   3.786


  43 in total

1.  Role of TLR4 and miR-155 in peripheral blood mononuclear cell-mediated inflammatory reaction in coronary slow flow and coronary arteriosclerosis patients.

Authors:  Jiangyan Huang; Qin Yang; Longmiao He; Jun Huang
Journal:  J Clin Lab Anal       Date:  2017-04-13       Impact factor: 2.352

Review 2.  The coronary slow flow phenomenon: characteristics, mechanisms and implications.

Authors:  Xiao Wang; Shao-Ping Nie
Journal:  Cardiovasc Diagn Ther       Date:  2011-12

3.  Relationship between serum visfatin levels and coronary slow-flow phenomenon.

Authors:  Huseyin Altug Cakmak; Serkan Aslan; Ahmet Arif Yalcin; Ibrahim Faruk Akturk; Burce Yalcin; Fatih Uzun; Derya Ozturk; Mehmet Erturk; Mehmet Gul
Journal:  Herz       Date:  2015-05-05       Impact factor: 1.443

Review 4.  Use of the TIMI frame count in the assessment of coronary artery blood flow and microvascular function over the past 15 years.

Authors:  Vijayalakshmi Kunadian; Caitlin Harrigan; Cafer Zorkun; Alexandra M Palmer; Katherine J Ogando; Leah H Biller; Erin E Lord; Scott P Williams; Michelle E Lew; Lauren N Ciaglo; Jacqueline L Buros; Susan J Marble; William J Gibson; C Michael Gibson
Journal:  J Thromb Thrombolysis       Date:  2008-04-20       Impact factor: 2.300

5.  Predictive Value of Neutrophil Lymphocyte Ratio and Platelet Lymphocyte Ratio in Patients with Coronary Slow Flow.

Authors:  Mustafa Çetin; Emrullah Kiziltunc; Özgül Uçar Elalmış; Zehra Güven Çetin; Muhammed Bora Demirçelik; Hülya Çiçekçioğlu; Alparslan Kurtul; Selçuk Özkan; Candan Mansuroğlu Avan; Ender Örnek; Feridun Vasfi Ulusoy
Journal:  Acta Cardiol Sin       Date:  2016-05       Impact factor: 2.672

6.  The association of serum albumin with coronary slow flow.

Authors:  Mustafa Cetin; Cemil Zencir; Hakan Tasolar; Erkan Baysal; Mehmet Balli; Erdal Akturk
Journal:  Wien Klin Wochenschr       Date:  2014-07-01       Impact factor: 1.704

7.  Evaluation of Tp-Te Interval and Tp-Te/QT Ratio in Patients with Coronary Slow Flow Tp-Te/QT Ratio and Coronary Slow Flow.

Authors:  Erhan Tenekecioglu; Kemal Karaagac; Osman Can Yontar; Fahriye Vatansever Agca; Ozlem Arican Ozluk; Ahmet Tutuncu; Burhan Arslan; Mustafa Yilmaz
Journal:  Eurasian J Med       Date:  2015-06

8.  Abnormal nail fold capillaroscopic findings in patients with coronary slow flow phenomenon.

Authors:  Serkan Yuksel; Esra Pancar Yuksel; Mustafa Yenercag; Korhan Soylu; Halit Zengin; Okan Gulel; Murat Meriç; Fatma Aydin; Nilgun Senturk; Mahmut Sahin
Journal:  Int J Clin Exp Med       Date:  2014-04-15

9.  Clinical analysis of the risk factors of slow coronary flow.

Authors:  Shuang Xia; Song-Bai Deng; Yang Wang; Jun Xiao; Jian-Lin Du; Yu Zhang; Xi-Chun Wang; Ye-Qing Li; Rui Zhao; Li He; Yu-Luan Xiang; Qiang She
Journal:  Heart Vessels       Date:  2011-01-05       Impact factor: 2.037

10.  Thrombin activatable fibrinolysis inhibitor : its role in slow coronary flow.

Authors:  M N Yildirim; Y Selcoki; S Uysal; A B Nacar; B Demircelik; H I Aydin; B Eryonucu
Journal:  Herz       Date:  2013-09-27       Impact factor: 1.443

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.